737 related articles for article (PubMed ID: 21888516)
1. Nanoparticle delivery of cancer drugs.
Wang AZ; Langer R; Farokhzad OC
Annu Rev Med; 2012; 63():185-98. PubMed ID: 21888516
[TBL] [Abstract][Full Text] [Related]
2. Design considerations for nanotherapeutics in oncology.
Stylianopoulos T; Jain RK
Nanomedicine; 2015 Nov; 11(8):1893-907. PubMed ID: 26282377
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle Therapy for Prostate Cancer: Overview and Perspectives.
Zhang J; Wang L; You X; Xian T; Wu J; Pang J
Curr Top Med Chem; 2019; 19(1):57-73. PubMed ID: 30686255
[TBL] [Abstract][Full Text] [Related]
4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
5. Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics.
Marchal S; El Hor A; Millard M; Gillon V; Bezdetnaya L
Drugs; 2015 Sep; 75(14):1601-11. PubMed ID: 26323338
[TBL] [Abstract][Full Text] [Related]
6. Applications of Nanoparticles for Anticancer Drug Delivery: A Review.
Zhu Y; Liao L
J Nanosci Nanotechnol; 2015 Jul; 15(7):4753-73. PubMed ID: 26373036
[TBL] [Abstract][Full Text] [Related]
7. Grand challenges in nanomedicine.
Wu LP; Wang D; Li Z
Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110302. PubMed ID: 31753337
[TBL] [Abstract][Full Text] [Related]
8. Advances in the use of nanocarriers for cancer diagnosis and treatment.
Vieira DB; Gamarra LF
Einstein (Sao Paulo); 2016; 14(1):99-103. PubMed ID: 27074238
[TBL] [Abstract][Full Text] [Related]
9. Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies.
Moradi Kashkooli F; Soltani M; Souri M
J Control Release; 2020 Nov; 327():316-349. PubMed ID: 32800878
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle-Delivered Chemotherapy: Old Drugs in New Packages.
Lee MS; Dees EC; Wang AZ
Oncology (Williston Park); 2017 Mar; 31(3):198-208. PubMed ID: 28299757
[TBL] [Abstract][Full Text] [Related]
11. Nanomedicines Targeting the Tumor Microenvironment.
Tong R; Langer R
Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic and diagnostic applications of nanoparticles.
Youns M; Hoheisel JD; Efferth T
Curr Drug Targets; 2011 Mar; 12(3):357-65. PubMed ID: 20955146
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnologies for noninvasive measurement of drug release.
Moore T; Chen H; Morrison R; Wang F; Anker JN; Alexis F
Mol Pharm; 2014 Jan; 11(1):24-39. PubMed ID: 24215280
[TBL] [Abstract][Full Text] [Related]
14. Stimuli Responsive Nanoparticles for Controlled Anti-cancer Drug Release.
Tang Q; Yu B; Gao L; Cong H; Song N; Lu C
Curr Med Chem; 2018; 25(16):1837-1866. PubMed ID: 29332566
[TBL] [Abstract][Full Text] [Related]
15. Improved Targeting of Cancers with Nanotherapeutics.
Foster C; Watson A; Kaplinsky J; Kamaly N
Methods Mol Biol; 2017; 1530():13-37. PubMed ID: 28150194
[TBL] [Abstract][Full Text] [Related]
16. Advances in the Use of Multifunctional Mesoporous Silica Nanoparticles and Related Nanomaterials as Carriers for the Cancer Treatment.
Song C; Wang X; Wang Y; Yu H; Cui Y; Ma T
Curr Drug Metab; 2018; 19(2):131-141. PubMed ID: 28758578
[TBL] [Abstract][Full Text] [Related]
17. Medicinal chemistry and nanomedicine for reproductive cancer therapeutics.
Majumdar D; Singhal S
Front Biosci (Elite Ed); 2012 Jan; 4(6):2029-44. PubMed ID: 22202018
[TBL] [Abstract][Full Text] [Related]
18. NanoTRAIL-Oncology: A Strategic Approach in Cancer Research and Therapy.
Shi Y; Pang X; Wang J; Liu G
Adv Healthc Mater; 2018 Jun; 7(11):e1800053. PubMed ID: 29527836
[TBL] [Abstract][Full Text] [Related]
19. Research progress of novel inorganic nanometre materials carriers in nanomedicine for cancer diagnosis and treatment.
Xu J; Liao K; Jiang H; Zhou W
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S492-S502. PubMed ID: 30449177
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicine tactics in cancer treatment: Challenge and hope.
Al-Zoubi MS; Al-Zoubi RM
Crit Rev Oncol Hematol; 2022 Jun; 174():103677. PubMed ID: 35385774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
